文献速递生殖医学产科母胎医学

延长胚胎培养后新鲜移植的母婴及儿童健康结局

Obstetrical, perinatal, and children's health outcomes following fresh embryo transfer after extended embryo culture.
PubMed 文献 · Hum Reprod · 2026-01-01

经多因素调整后,延长培养未显示广泛风险增加,但心脏畸形等少数结局风险中度升高,而妊娠期糖尿病、低出生体重和骨骼肢体畸形风险降低。

要点

  • 延长培养与心脏畸形风险升高相关(aHR 1.78,95%CI 1.21-2.60)
  • 延长培养与前置胎盘和新生儿重症监护入院风险轻度升高相关
  • 延长培养与妊娠期糖尿病、低出生体重及骨骼肢体畸形风险降低相关

核心结论

  • 经充分调整后,延长胚胎培养未伴随广泛的母婴及儿童健康风险增加。
  • 少数特定结局风险中度升高,包括心脏畸形、前置胎盘和新生儿重症监护入院。
  • 妊娠期糖尿病、低出生体重和骨骼肢体畸形风险则降低。

研究设计与样本

  • 法国全国性纵向队列研究,纳入2014—2019年经体外受精(伴或不伴卵胞浆内单精子注射)新鲜胚胎移植后活产单胎,随访至8岁。
  • 数据来自法国国家健康系统与国家生物医学机构登记库,采用多变量逻辑回归和生存模型调整母方、父方及治疗相关因素。

主要发现

  • 延长培养组前置胎盘风险升高(aOR 1.16;95%CI 1.02-1.30)。
  • 延长培养组新生儿重症监护入院风险升高(aOR 1.16;95%CI 1.05-1.29)。
  • 延长培养组3岁时心脏畸形风险升高(aHR 1.78;95%CI 1.21-2.60)。
  • 延长培养组妊娠期糖尿病风险降低(aOR 0.94;95%CI 0.88-1.00;P=0.041),低出生体重风险降低(aOR 0.94;95%CI 0.88-1.00;P=0.039)。
  • 延长培养组骨骼肢体畸形风险降低(aHR 0.63;95%CI 0.42-0.97),该关联持续至7岁。

临床怎么用

  • 咨询时可告知患者延长培养总体未显示广泛风险增加,但需关注心脏畸形等少数结局的轻度风险升高。
  • 对延长培养妊娠应加强前置胎盘和新生儿重症监护需求的监测。
  • 特定畸形关联基于少量病例,解释时应谨慎并结合个体情况。

局限性

  • 研究仅纳入活产单胎,死产和医学终止妊娠被排除。
  • 尽管进行了广泛调整,仍不能排除残余混杂。
  • 部分亚组病例数较少,特定疾病/畸形的结果应谨慎解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does extended embryo culture (EEC) associate with an increased risk of obstetrical, perinatal, or children's health complications? SUMMARY ANSWER: After thorough adjustment, EEC was not associated with widespread increased risks, although a moderate excess risk persisted for a few specific outcomes, notably cardiac anomalies, whereas reduced risks were observed for gestational diabetes, small birthweight, and musculoskeletal-limb anomalies. WHAT IS KNOWN ALREADY: EEC is increasingly used in IVF cycles. While blastocyst transfer (day-5/6) often improves birth rates, concerns remain about its impact on maternal and child health. STUDY DESIGN, SIZE, DURATION: In this nationwide longitudinal cohort study, all live-born singletons conceived through IVF-with or without sperm microinjection-and following fresh embryo transfer between 2014 and 2019 in France were included and followed for up to 8 years. PARTICIPANTS/MATERIALS, SETTING, METHODS: Data were obtained from the French National Health System and the National Biomedicine Agency registries. A comparative study was conducted between singletons conceived at either day-2/3 (cleavage-stage embryos group) or day-5/6 (EEC group). Data from both registries were cross-linked to identify obstetrical, perinatal, and health outcomes, including major congenital malformations, hospitalizations, and surgical interventions. Multivariable logistic and survival models were used to adjust for maternal, paternal, and treatment-related factors. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 41 315 singletons were included (25 816 and 15 499 from day-2/3 and day-5/6 groups, respectively). Most outcomes were similar between groups, notably the incidence of global major congenital malformations. However, EEC was associated with increased risks of placenta praevia (aOR, 1.16; 95% CI, 1.02-1.30), admission in neonatal intensive care unit (aOR, 1.16; 95% CI, 1.05-1.29), and cardiac anomalies at age 3 years (aHR, 1.78; 95% CI, 1.21-2.60). Conversely, the risk of gestational diabetes (aOR, 0.94; 95% CI, 0.88-1.00; P = 0.041) and small birthweight (aOR, 0.94; 95% CI, 0.88-1.00, P = 0.039) was lower, as was the risk of musculoskeletal-limb anomalies (aHR, 0.63; 95% CI, 0.42-0.97)-a finding that persisted up to age 7. Other health outcomes were largely comparable. LIMITATIONS, REASONS FOR CAUTION: One limitation of this study is that the data refer to live-born singletons, with stillbirths and medical terminations excluded from the analyses. Despite extensive adjustments, residual confounding cannot be excluded. Findings for specific pathologies/malformations should be interpreted with caution because the number of cases was small in some sub-groups. WIDER IMPLICATIONS OF THE FINDINGS: In this large and unique study, after adjusting for multiple maternal, paternal, and cycle-related variables, our findings provide some reassurance regarding the safety of prolonged in vitro embryo culture. A moderate risk remained for a few maternal and child health conditions following EEC-warranting further investigation-whereas the risk was notably lower compared to short embryo culture, particularly for musculoskeletal-limb anomalies. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the AOI of University Hospital of Dijon. The authors have no competing interests to disclose. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Fauque P, Cottenet J, Firmin J, et al. Obstetrical, perinatal, and children's health outcomes following fresh embryo transfer after extended embryo culture. Hum Reprod. 2026. PMID: 41453370. doi:10.1093/humrep/deaf245

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。